NCT01510366View on ClinicalTrials.gov

The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains(Sabin IPV)

PHASE3CompletedINTERVENTIONAL
Enrollment

1,200

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Poliomyelitis
Interventions
BIOLOGICAL

Inactivated Poliomyelitis Vaccine (Sabin strains)

Inactivated Poliomyelitis Vaccine (Sabin strains) 3 x 0.5ml intramuscular injections, one month apart.

BIOLOGICAL

Inactivated Poliomyelitis Vaccine (Salk strains)

Inactivated Poliomyelitis Vaccine (Salk strains)3 x 0.5ml intramuscular injections, one month apart.

Trial Locations (2)

530400

Pingle Center for Disease Prevention and Control, Guilin

Bingyang Center for Disease Prevention and Control, Nanning

All Listed Sponsors
collaborator

Guangxi Center for Disease Control and Prevention

OTHER_GOV

collaborator

National Institute for the Control of Pharmaceutical and Biological Products, China

OTHER

lead

Institute of Medical Biology, Chinese Academy of Medical Sciences

OTHER

NCT01510366 - The Clinical Trial Protocol for the Inactivated Poliomyelitis Vaccine Made From Sabin Strains(Sabin IPV) | Biotech Hunter | Biotech Hunter